E³ - ECR Master Class: Neuro
E³ 726 - Emerging non-surgical treatment complications in neuroradiology
Lectures
1
Chairperson's introduction
05:00Sven Haller, Geneve / CH
2
Radiotherapy-related side effects on the healthy brain
15:00Jasmina Boban, Novi Sad / RS
3
Neurologic complications of immunotherapy
15:00Teresa Santos Nunes, Lisboa / PT
4
Complications of new drug treatments in neurodegeneration
15:00Frederik Barkhof, Amsterdam / NL
5
Panel discussion: Challenges in imaging interpretation of treatment-related complications
10:00Panel discussion: Challenges in imaging interpretation of treatment-related complications
5 min
Chairperson's introduction
Sven Haller, Geneve / Switzerland
15 min
Radiotherapy-related side effects on the healthy brain
Jasmina Boban, Novi Sad / Serbia
1. To review the current knowledge of the mechanism for the radiotherapy-induced and radiotherapy-related side effects on the healthy brain and to introduce the term "radiobrain".
2. To provide the overview of the typical imaging findings of the radiotherapy-related side effects.
3. To present the pitfalls and common mistakes in interpreting these effects.
4. To provide a short insight into current research perspectives in the field.
2. To provide the overview of the typical imaging findings of the radiotherapy-related side effects.
3. To present the pitfalls and common mistakes in interpreting these effects.
4. To provide a short insight into current research perspectives in the field.
15 min
Neurologic complications of immunotherapy
Teresa Santos Nunes, Lisboa / Portugal
1. To describe the neurological complications associated with immunotherapy.
2. To summarise the imaging features of neurologic immune-related adverse events.
3. To discuss the challenges in interpreting neuroimaging findings during immunotherapy.
2. To summarise the imaging features of neurologic immune-related adverse events.
3. To discuss the challenges in interpreting neuroimaging findings during immunotherapy.
15 min
Complications of new drug treatments in neurodegeneration
Frederik Barkhof, Amsterdam / Netherlands
1. To become familiar with novel antibody treatments for Alzheimer's disease.
2. To recognise the features of Amyloid-Related Imaging Abnormalities (ARIA).
3. To be able to communicate ARIA findings in the setting of treatment monitoring.
2. To recognise the features of Amyloid-Related Imaging Abnormalities (ARIA).
3. To be able to communicate ARIA findings in the setting of treatment monitoring.
10 min
Panel discussion: Challenges in imaging interpretation of treatment-related complications